Trinity Biotech (TRIB) Net Income towards Common Stockholders Growth (5y) (2014 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -62.47% |
| Sep 30, 2024 | -30.56% |
| Jun 30, 2024 | -23.31% |
| Mar 31, 2024 | -26.14% |
| Dec 31, 2023 | -29.80% |
| Sep 30, 2023 | -35.95% |
| Jun 30, 2023 | -52.35% |
| Mar 31, 2023 | -32.23% |
| Dec 31, 2022 | -66.77% |
| Sep 30, 2022 | -41.28% |
| Jun 30, 2022 | -14.90% |
| Mar 31, 2022 | -48.12% |
| Dec 31, 2021 | 40.00% |
| Sep 30, 2021 | 59.68% |
| Jun 30, 2021 | -14.87% |
| Mar 31, 2021 | 45.27% |
| Dec 31, 2020 | 25.93% |
| Sep 30, 2020 | -3.76% |
| Jun 30, 2020 | -10.94% |
| Mar 31, 2020 | -7.93% |
| Dec 31, 2019 | -17.73% |
| Sep 30, 2019 | -11.46% |
| Jun 30, 2019 | 10.72% |
| Mar 31, 2019 | -10.48% |
| Dec 31, 2018 | -9.59% |
| Sep 30, 2018 | -15.47% |
| Jun 30, 2018 | -7.05% |
| Mar 31, 2018 | -7.27% |
| Dec 31, 2017 | -29.03% |
| Sep 30, 2017 | -12.55% |
| Jun 30, 2017 | -10.17% |
| Mar 31, 2017 | -13.25% |
| Dec 31, 2016 | -58.73% |
| Sep 30, 2016 | -15.34% |
| Jun 30, 2016 | -14.47% |
| Mar 31, 2016 | -17.08% |
| Sep 30, 2015 | 88.89% |
| Jun 30, 2015 | -41.85% |
| Mar 31, 2015 | 4.34% |
| Dec 31, 2014 | 6.66% |
| Sep 30, 2014 | 5.12% |
| Jun 30, 2014 | 4.10% |
| Mar 31, 2014 | 9.09% |